|
Industry Groups Call Out CMC Over New EU Labeling Requirement
Implementing a new labeling requirement by the EU’s Central Management Committee (CMC) on Medical Devices will raise devicemakers’ costs without any benefit to patient safety, industry association Eucomed says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
Devicemakers Must ‘Act Now’ on Objections to EU Device RegulationsRapporteur Seeks Stricter Controls Over Clinical IVD Trials, Genetic TestingIVD Makers Face ‘Quantum Leap’ in Requirements Under Proposed EU RegRapporteur for IVD Regulation Seeks Stricter Controls Over Clinical Trials, Genetic Testing
|
Subscribe
Archives